Difference between revisions of "ISMRM/QIBA PDFF Biomarker Ctte"
Jump to navigation
Jump to search
(Created page with " :Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD :RSNA Staff Support: Susan Stanfa * [https://docs.google.com/spreadsheets/d/e/2PACX-1vQZBtnrVMpQOU8BEKlY_4hs21JQoEhq...") |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | :Co-chairs: | + | :Co-chairs: Diego Hernando, PhD; Houchun (Harry) Hu, PhD |
| − | : | + | :ISMRM Staff Support: Gerardo Mopera |
| + | |||
* [https://docs.google.com/spreadsheets/d/e/2PACX-1vQZBtnrVMpQOU8BEKlY_4hs21JQoEhq_926-HCFtPm77AHzJ3-dp_S6cedeDfbIIILljxJVongZMJsb/pubhtml?gid=1460430101&single=true Roster] | * [https://docs.google.com/spreadsheets/d/e/2PACX-1vQZBtnrVMpQOU8BEKlY_4hs21JQoEhq_926-HCFtPm77AHzJ3-dp_S6cedeDfbIIILljxJVongZMJsb/pubhtml?gid=1460430101&single=true Roster] | ||
| − | The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF. | + | The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF. This effort is supported by ISMRM, using the QIBA Process for Profile development. |
| Line 12: | Line 13: | ||
<br />Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on February 3, 2022. | <br />Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on February 3, 2022. | ||
| + | *[[Media:2023_01-26_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|January 26, 2023]] | ||
| + | *[[Media:2022_02-03_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|February 3, 2022]] | ||
*[[Media:2021_04-01_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|April 1, 2021]] | *[[Media:2021_04-01_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|April 1, 2021]] | ||
| − | |||
| − | |||
'''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | '''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | ||
Latest revision as of 16:00, 21 December 2023
- Co-chairs: Diego Hernando, PhD; Houchun (Harry) Hu, PhD
- ISMRM Staff Support: Gerardo Mopera
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF. This effort is supported by ISMRM, using the QIBA Process for Profile development.
Meetings
Approved call summaries:
Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on February 3, 2022.
PDFF Biomarker Committee Call Summaries Archive